Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 169

Results For "market"

3620 News Found

Lupin acquires five brands from Menarini
News | September 23, 2023

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021


Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
News | September 22, 2023

Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr

Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction


Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’
Drug Approval | September 21, 2023

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway


Jupiter Life Line Hospitals lists at 32.38% premium
News | September 20, 2023

Jupiter Life Line Hospitals lists at 32.38% premium

The market capitalization of the company stood at Rs. 7,000 crore +


INEOS Styrolution Introduces New ASA Grade for small medical devices
Medical Device | September 20, 2023

INEOS Styrolution Introduces New ASA Grade for small medical devices

Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings


Biovyn PVC to be used in sustainable prosthetics for the first time
News | September 20, 2023

Biovyn PVC to be used in sustainable prosthetics for the first time

Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell


Remedi introduces best handheld X-ray solution to India
Medical Device | September 19, 2023

Remedi introduces best handheld X-ray solution to India

This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses


CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Clinical Trials | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy


Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for  cell lung cancer
Drug Approval | September 18, 2023

Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial